Displaying drugs 2776 - 2780 of 2780 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Zilucoplan | 3562.229 C172H278N24O55 |  | A complement inhibitor used to treat generalized myasthenia gravis in anti-acetylcholine receptor (AChR) antibody-positive adults. | Amino Acids, Peptides, and Proteins / Blood Proteins / Complement Inactivating Agents / Immunoproteins / Peptides / Proteins |
| Pramlintide | 3949.44 C171H267N51O53S2 |  | An amylin analog used for the management of type 1 and type 2 diabetes mellitus as an adjunct to preprandial insulin therapy in patients without adequate glycemic control of insulin therapy. | Amylin Analog |
| Semaglutide | 4113.641 C187H291N45O59 |  | A glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular events in selected adults. | Glucagon-like peptide-1 (GLP-1) analogues |
| Tetracycline phosphate complex | 4821.729 C198H225N18NaO102P10 |  | Not Annotated | Anti-Bacterial Agents |
| Lumefantrine co-artemether | 6116.74 C346H378Cl33N11O16 |  | Lumefantrine Co-Artemether (Riamet) has been investigated for the treatment of Malaria, Malaria, Falciparum, Malaria in Pregnancy, Uncomplicated Malaria, and Uncomplicated Knowlesi Malaria. Lumefantrine Co-Artemether is a tablet formulation of artemether... | Not Annotated |
Displaying drugs 2776 - 2780 of 2780 in total